Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thompson HHS Will Consider Medicare Rx Bill If Block Grants Are Not Viable

Executive Summary

HHS will consider Medicare Rx-only proposals as a fall-back option if the incoming Administration's state block grant proposal is not politically viable, HHS Secretary-designate Tommy Thompson told the Senate Health Committee Jan. 19.

You may also be interested in...



Medicaid Rx Coverage Expands In Three States With CHIP Waivers

New Jersey will use prescription drug co-pays in its expanded health insurance coverage to parents of children eligible under either the State Children's Health Insurance Program or Medicaid.

Medicaid Rx Coverage Expands In Three States With CHIP Waivers

New Jersey will use prescription drug co-pays in its expanded health insurance coverage to parents of children eligible under either the State Children's Health Insurance Program or Medicaid.

Drug Companies, Insurers Can Agree On Broad Medicare Reforms, Lilly Says

Pharmaceutical manufacturers and health insurance companies can agree on broad Medicare reforms and the long-term objective of incorporating drug coverage into an integrated senior benefit, Lilly Chairman Sidney Taurel told a National Press Club luncheon in Washington, D.C. Jan. 18.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037231

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel